Assessing the Current and Future Landscape of Postoperative Ocular Inflammation and Pain: Where We Are and Where We Are Going

Activity Description & Educational Objectives

In this two-part activity, experts discuss the prevention and management of postoperative ocular inflammation and pain in patients undergoing cataract surgery. The activity explores the benefits of anti-inflammatory agents used in this setting and reviews the efficacy and potential adverse effects associated with topical NSAIDs and corticosteroids. Practical considerations for selecting an appropriate anti-inflammatory regimen in individual patients undergoing cataract surgery are also provided.

Upon completion of this activity, participants should be better able to:

• Apply recent efficacy and safety data pertaining to available and emerging therapies for the management of postoperative ocular inflammation and pain
• Select an appropriate course of therapy for the prevention and management of postoperative ocular inflammation and pain in individual patients undergoing cataract surgery

Target Audience

This activity has been designed to meet the educational needs of ophthalmologists and other healthcare professionals involved in the management of patients undergoing cataract surgery.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: September 11, 2012 - September 10, 2013
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Interviewee

Stephen S. Lane, MD
Medical Director
Associated Eye Care
Adjunct Clinical Professor
University of Minnesota
Minneapolis, Minnesota

Stephen S. Lane, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Medical Optics; Alcon Laboratories, Inc; Bausch & Lomb; Inspire Pharmaceuticals, Inc. (Merck & Co., Inc.); ISTA Pharmaceuticals; Ocular Therapeutics; PowerVision, Inc.; SARcode Bioscience, Inc.; SMI; SRxA; TearScience; VisionCare Ophthalmic Technologies; and WaveTec Vision.

Grant/Research Support from Bausch & Lomb.

Other Financial or Material Support from Alcon Laboratories, Inc. and Bausch & Lomb in the form of lecture fees.

Interviewee

Uday Devgan, MD
Private Practice, Devgan Eye Surgery
Chief of Ophthalmology
Olive View UCLA Medical Center
Associate Clinical Professor
Jules Stein Eye Institute, UCLA School of Medicine
Los Angeles, California

Uday Devgan, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Bausch & Lomb; Hoya Surgical Optics; ISTA Pharmaceuticals; and Gerson Lehrman Group, Inc.

Speakers Bureau participant with Alcon Laboratories, Inc.; Bausch & Lomb; Carl Zeiss Meditec, Inc.; Hoya Surgical Optics; Haag-Streit AG; ISTA Pharmaceuticals; and Ocular Surgery News (Slack Incorporated).

Shareholder in ISTA Pharmaceuticals and Specialty Surgical.

Other Financial or Material Support from Accutome in the form of royalties/patents.

Medical Director

Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education

Kirk A. Tacka, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5181-13-T.

This CME activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by educational grants from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.